Due to the dual role of TEX in promoting tumor growth and as a therapeutic carrier, to overcome the tumor-promoting risk of TEX during treatment (324), immunotherapy combining immune system activation with immune escape inhibitors has been shown to be a new effective tumor suppression strategy, Fan et al. The gene discussed is TEX46; the disease is neoplasm.